S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
BGMS · Bio Green Med Solution, Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
Bio Green Med Solution Inc (BGMS)
NASDAQ NMS - GLOBAL MARKET
Biotechnology
$1.01
+0.04
(+4.60%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$1.01
$1.01
$1.01
52-WEEK RANGE
$1.01
$0.57
$3.90
What's happening
- BGMS is up 4.60% today, trading at $1.01. — Live quote
- Volume today (106) is well below its 3-month average of 97,490. (Finnhub fundamentals)
- Reports earnings on 2026-11-11, 20 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $-43.20 actual vs. $-135.86 estimated (+68.2%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 0
Buy 0
Hold 3
Sell 1
Strong sell 2
Aggregate ratings for 2025-02-01 (6 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
BGMS
-36.49%
vs S&P 500
-49.26%
1-YEAR RETURN
BGMS
-68.35%
vs S&P 500
-82.91%
6-MONTH RETURN
BGMS
-10.48%
3-MONTH RETURN
BGMS
+6.21%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2024-10-26 (Q3 2024)
$-43.20
Est. $-135.86
BEAT +68.2%
2024-07-26 (Q2 2024)
$-172.80
Est. $-351.29
BEAT +50.8%
2024-04-26 (Q1 2024)
$-544.80
Est. $-1161.58
BEAT +53.1%
2024-01-26 (Q4 2023)
$-1495.20
Est. $-1442.69
MISS -3.6%
Valuation Measures & Ratios
Enterprise Value4$2.5M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)3.40
Price / Book70.84
EV4 / Revenue1.36
EV4 / EBITDA—
Profit Margin-118.27%
Operating Margin-147.13%
Return on Equity (ROE8)-31.60%
Return on Assets (ROA9)-27.72%
Avg Volume (3M)97,490
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | — | — | $3.7M | $1.5M | — |
| P/E | — | — | -0.84 | -0.22 | — |
| Price/Book | — | — | 0.51 | 0.40 | — |
| ROE | — | — | -61.22% | -182.13% | — |
| ROA | — | — | -53.25% | -150.26% | — |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short5,591
Change from Prior Settlement-93.84%
% of Float—
Days to Cover (Short Ratio)1.00
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 8-K, filed 2026-10-16; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is -118.3%. Finnhub fundamentals ↗
- Trailing 52-week price return is -68.4%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on BGMS
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $743.0K | — | — | — | — | — | — |
| Operating income | -$418.0K | -$246.0K | -$992.0K | -$1.2M | -$4.2M | -$2.2M | -$3.6M | -$4.4M |
| Net income | -$405.0K | -$197.0K | -$988.0K | -$1.3M | -$81.0K | -$2.0M | -$3.3M | -$2.9M |
| EPS (diluted) | — | — | $-1.31 | $-0.98 | $0.00 | $-43.80 | $-172.18 | $-2.27 |
| EPS (basic) | — | — | $-1.31 | $-0.98 | $0.00 | $-43.80 | $-172.18 | $-2.27 |
| Operating margin | — | -$33 | — | — | — | — | — | — |
| Net margin | — | -$27 | — | — | — | — | — | — |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Sep '25 | Jun '25 | Mar '25 | Jan '25 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $7.9M | $7.6M | $8.2M | $8.2M | — | $4.4M | $3.7M | — |
| Total liabilities | $694.0K | $804.0K | $1.3M | $1.1M | — | $770.0K | $672.0K | — |
| Stockholders' equity | $7.2M | $6.8M | $6.8M | $7.1M | — | $3.6M | $3.1M | — |
| Total current assets | $6.0M | $5.6M | $6.3M | $6.4M | — | $4.4M | $3.7M | — |
| Total current liabilities | $692.0K | $796.0K | $1.3M | $1.0M | — | $760.0K | $663.0K | — |
| Cash & equivalents | $3.8M | $3.3M | $3.5M | $3.8M | — | $4.3M | $3.5M | — |
| Marketable securities (current) | — | — | — | — | — | — | — | — |
| Accounts receivable | $1.1M | $1.2M | $1.3M | $725.0K | — | — | — | — |
| Inventory | $972.0K | $947.0K | $1.4M | $1.4M | — | — | — | — |
| Other current assets | — | — | — | $460.0K | — | $58.0K | $194.0K | — |
| Property, plant & equipment | $136.0K | $138.0K | $137.0K | $129.0K | — | $1.0K | $1.0K | — |
| Goodwill | $1.6M | $1.6M | $1.6M | $1.6M | $1.57B | — | — | — |
| Accounts payable | $189.0K | $256.0K | $617.0K | $468.0K | — | $221.0K | $114.0K | — |
| Accrued liabilities | $503.0K | $540.0K | $715.0K | $534.0K | — | $539.0K | $549.0K | — |
| Other current liabilities | — | — | — | — | — | — | — | — |
| Other non-current liabilities | — | — | — | — | — | — | — | — |
| Common stock & paid-in capital | $7.0K | $5.0K | $5.0K | $3.0K | — | $2.0K | $204.0K | — |
| Retained earnings | -$455.0M | -$454.6M | -$454.4M | -$444.3M | — | -$441.8M | -$440.5M | — |
| Accumulated other comprehensive income (loss) | — | -$30.0K | -$39.0K | — | — | — | — | $900.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$352.0K | -$278.0K | -$33.0K | -$434.0K | -$1.1M | -$3.2M | -$1.4M | -$3.1M |
| Investing cash flow | $0 | -$1.0K | — | — | — | — | — | $0 |
| Financing cash flow | $773.0K | $105.0K | -$259.0K | -$3.0K | $1.9M | $3.6M | $1.6M | -$1.0K |
| Free cash flow | -$352.0K | -$279.0K | — | — | — | — | — | -$3.1M |
| Capital expenditures | $0 | $1.0K | — | — | — | — | — | $0 |
| Depreciation & amortization | — | — | — | — | — | — | — | — |
| Share-based compensation | $0 | $1.0K | $655.0K | $6.0K | $7.0K | $1.7M | $93.0K | $107.0K |
| Change in accounts receivable | -$114.0K | -$69.0K | $532.0K | $725.0K | — | — | — | — |
| Change in inventory | $25.0K | -$437.0K | $16.0K | $1.4M | — | — | — | — |
| Change in accounts payable | — | — | — | — | — | — | — | — |
| Other investing activities | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $0 | $43.0K | — | — | — |
| Operating income | -$8.4M | -$12.0M | -$25.5M | -$27.7M | -$22.9M |
| Net income | -$3.0M | -$11.2M | -$22.6M | -$21.2M | -$18.9M |
| EPS (diluted) | $-6.45 | $-502.46 | $-26.75 | $-27.24 | $-2.14 |
| EPS (basic) | $-6.45 | $-502.46 | $-26.75 | $-1.90 | $-2.14 |
| Operating margin | — | -$27.9K | — | — | — |
| Net margin | — | -$26.1K | — | — | — |
Balance sheet
| Line item | Dec '25 | Sep '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| Total assets | $8.2M | — | $4.1M | $8.8M | $28.1M |
| Total liabilities | $1.3M | — | $6.3M | $8.2M | $7.6M |
| Stockholders' equity | $6.8M | — | -$2.2M | $607.0K | $15.9M |
| Total current assets | $6.3M | — | $3.7M | $7.4M | $24.4M |
| Total current liabilities | $1.3M | — | $6.3M | $8.2M | $7.5M |
| Cash & equivalents | $3.5M | — | $3.1M | $3.4M | $18.3M |
| Marketable securities (current) | — | — | — | — | $4.5M |
| Accounts receivable | $1.3M | — | — | — | — |
| Inventory | $1.4M | — | — | — | — |
| Other current assets | — | — | $300.0K | $341.0K | $426.0K |
| Property, plant & equipment | $137.0K | — | $3.0K | $9.0K | $32.0K |
| Goodwill | $1.6M | $1.57B | — | — | — |
| Accounts payable | $617.0K | — | $4.6M | $3.5M | $2.6M |
| Accrued liabilities | $715.0K | — | $1.7M | $4.6M | $5.0M |
| Other current liabilities | — | — | — | — | — |
| Other non-current liabilities | — | — | — | — | — |
| Common stock & paid-in capital | $5.0K | — | $9.0K | $1.0K | $1.0K |
| Retained earnings | -$454.4M | — | -$439.5M | -$428.3M | -$405.7M |
| Accumulated other comprehensive income (loss) | -$39.0K | — | -$891.0K | -$908.0K | -$1.3M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$4.8M | -$8.0M | -$16.1M | -$20.8M | -$18.5M |
| Investing cash flow | — | — | -$6.0K | -$7.0K | -$27.0K |
| Financing cash flow | $5.3M | $7.8M | $848.0K | $3.0M | $21.7M |
| Free cash flow | — | — | -$16.1M | -$20.8M | -$18.6M |
| Capital expenditures | — | — | $6.0K | $7.0K | $27.0K |
| Depreciation & amortization | — | — | — | — | — |
| Share-based compensation | $2.3M | $592.0K | $1.5M | $1.5M | $1.2M |
| Change in accounts receivable | $1.3M | — | — | — | — |
| Change in inventory | $1.4M | — | — | — | — |
| Other investing activities | — | — | — | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding BGMS as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2025-09-04 to 2025-11-12
Recent transactions
- Most recent: Kiu Cu Seng (Chief Financial Officer) — Grant / award of 200,000 shares on 2025-11-12.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)0 sh(0 txns)
Net Shares+0
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Kiu Cu Seng | Chief Financial Officer | Grant / award | 2025-11-12 | 200,000 |
| Doris Wong Sing Ee | Chief Executive Officer | Grant / award | 2025-11-12 | 300,178 |
| Yap Kim Choy | 10% owner | Open market sale | 2025-11-05 | 28,540 |
| Kua Khai Loon | 10% owner | Other acquisition/disposition | 2025-11-05 | 467,535 |
| Ong Yee Lung | 10% owner | Other acquisition/disposition | 2025-11-05 | 467,535 |
| FITTERS Diversified Berhad | 10% owner | Open market sale | 2025-10-21 | 92,352 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2025-11-12 | Kiu Cu Seng | Chief Financial Officer | Grant / award | 200,000 | $1.40 |
| 2025-11-12 | Doris Wong Sing Ee | Chief Executive Officer | Grant / award | 300,178 | $1.40 |
| 2025-11-05 | Yap Kim Choy | 10% owner | Open market sale | 28,540 | $1.70 |
| 2025-11-05 | Yap Kim Choy | 10% owner | Other acquisition/disposition | 467,535 | $0.00 |
| 2025-11-05 | Kua Khai Loon | 10% owner | Other acquisition/disposition | 467,535 | $0.00 |
| 2025-11-05 | Ong Yee Lung | 10% owner | Other acquisition/disposition | 467,535 | $0.00 |
| 2025-10-30 | Yap Kim Choy | 10% owner | Open market sale | 112,260 | $1.81 |
| 2025-10-30 | Kua Khai Loon | 10% owner | Open market sale | 242,477 | $1.80 |
| 2025-10-30 | Ong Yee Lung | 10% owner | Open market sale | 248,814 | $1.80 |
| 2025-10-29 | Yap Kim Choy | 10% owner | Open market sale | 110,749 | $1.83 |
| 2025-10-28 | Yap Kim Choy | 10% owner | Open market sale | 13,111 | $1.83 |
| 2025-10-27 | Yap Kim Choy | 10% owner | Open market sale | 120,250 | $2.12 |
| 2025-10-24 | Ong Yee Lung | 10% owner | Open market sale | 19,858 | $1.99 |
| 2025-10-24 | Yap Kim Choy | 10% owner | Open market sale | 19,595 | $1.90 |
| 2025-10-21 | FITTERS Diversified Berhad | 10% owner | Open market sale | 92,352 | $3.00 |
| 2025-10-20 | FITTERS Diversified Berhad | 10% owner | Open market sale | 108,107 | $3.09 |
| 2025-10-16 | Kua Khai Loon | 10% owner | Open market sale | 88,204 | $4.22 |
| 2025-10-16 | FITTERS Diversified Berhad | 10% owner | Open market sale | 26,051 | $5.50 |
| 2025-10-15 | Kua Khai Loon | 10% owner | Open market sale | 7,479 | $5.66 |
| 2025-10-14 | Ong Yee Lung | 10% owner | Open market sale | 135,793 | $6.00 |
| 2025-10-10 | FITTERS Diversified Berhad | 10% owner | Open market sale | 51,400 | $5.26 |
| 2025-10-08 | FITTERS Diversified Berhad | 10% owner | Open market sale | 142,000 | $5.29 |
| 2025-09-16 | Kua Khai Loon | 10% owner | Open market sale | 25,000 | $5.13 |
| 2025-09-12 | Kua Khai Loon | 10% owner | Open market sale | 22,251 | $6.22 |
| 2025-09-05 | Kua Khai Loon | 10% owner | Open market sale | 19,054 | $7.01 |
| 2025-09-04 | Yap Kim Choy | 10% owner | Other acquisition/disposition | 186,465 | — |
| 2025-09-04 | Kua Khai Loon | 10% owner | Other acquisition/disposition | 186,465 | — |
| 2025-09-04 | Ong Yee Lung | 10% owner | Other acquisition/disposition | 186,465 | — |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-21 23:13 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-16 | 8-K | 2026-10-16 | View on SEC.gov → |
| 2026-08-14 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-14 | 8-K | 2026-08-12 | View on SEC.gov → |
| 2026-07-01 | 8-K | 2026-07-01 | View on SEC.gov → |
| 2026-06-22 | 8-K | 2026-06-18 | View on SEC.gov → |
| 2026-06-10 | 8-K | 2026-06-10 | View on SEC.gov → |
| 2026-06-04 | 8-K | 2026-06-04 | View on SEC.gov → |
| 2026-05-15 | 10-Q | 2026-03-31 | View on SEC.gov → |
| 2026-05-14 | 8-K | 2026-05-14 | View on SEC.gov → |
| 2026-04-13 | 8-K | 2026-04-13 | View on SEC.gov → |
| 2026-03-30 | 10-K | 2025-12-31 | View on SEC.gov → |
| 2026-03-30 | 8-K | 2026-03-30 | View on SEC.gov → |
Recent news
Headlines about BGMS (Bio Green Med Solution, Inc.). Links open the publisher — we don’t host full articles.
-
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 2026-10-19 -
LOVE,RARE,BGMS,BRT,TOWN,LLY,CNXC,ANGO,CBL,JOBY | Stock Prices | Quote Comparison
Yahoo! Finance Canada · 2026-10-17 -
BGMS 8-K & SEC Filings
Yahoo Finance · 2026-10-16 -
Firstborn Top Capital, a Licensed Private Financing Company in Malaysia, to Become Publicly Traded Via Business Combination with ARC Group Acquisition I Corp
Yahoo Finance · 2026-09-10 -
Bio Green Med Solution GAAP EPS of -$0.08, revenue of $0.34M
Seeking Alpha · 2026-08-12 -
BIO GREEN MED SOLUTION REPORTS SECOND QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Yahoo Finance · 2026-08-12 -
BIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN. BHD.
Yahoo Finance · 2026-06-04 -
BIO GREEN MED SOLUTION REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Yahoo Finance · 2026-05-14
No headlines in this category right now — try “All”.